DEA Office of Diversion Control
E13231
The DEA Office of Diversion Control is the division of the U.S. Drug Enforcement Administration responsible for preventing, investigating, and regulating the diversion of legal controlled substances into illegal channels.
All labels observed (4)
| Label | Occurrences |
|---|---|
| DEA Diversion Control | 1 |
| DEA Diversion Control Program | 1 |
| DEA Office of Diversion Control canonical | 1 |
| Office of Diversion Control | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T108268 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: DEA Office of Diversion Control Context triple: [Drug Enforcement Administration, hasDivision, DEA Office of Diversion Control]
-
A.
Drug Enforcement Administration
The Drug Enforcement Administration is a United States federal law enforcement agency responsible for combating drug trafficking and distribution and enforcing the nation’s controlled substances laws.
-
B.
Bureau of Narcotics and Dangerous Drugs
The Bureau of Narcotics and Dangerous Drugs was a former U.S. federal agency responsible for enforcing drug control laws before its functions were absorbed into the Drug Enforcement Administration (DEA).
-
C.
Office of National Drug Control Policy
The Office of National Drug Control Policy is a U.S. federal agency that coordinates and oversees national drug-control strategy and policies across the government.
-
D.
DEA Special Operations Division
The DEA Special Operations Division is a specialized unit within the U.S. Drug Enforcement Administration that coordinates high-level, often international, counter-narcotics investigations and intelligence operations.
-
E.
DEA Intelligence Division
The DEA Intelligence Division is the branch of the U.S. Drug Enforcement Administration responsible for collecting, analyzing, and disseminating drug-related intelligence to support law enforcement operations and policy decisions.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: DEA Office of Diversion Control Target entity description: The DEA Office of Diversion Control is the division of the U.S. Drug Enforcement Administration responsible for preventing, investigating, and regulating the diversion of legal controlled substances into illegal channels.
-
A.
Drug Enforcement Administration
The Drug Enforcement Administration is a United States federal law enforcement agency responsible for combating drug trafficking and distribution and enforcing the nation’s controlled substances laws.
-
B.
Bureau of Narcotics and Dangerous Drugs
The Bureau of Narcotics and Dangerous Drugs was a former U.S. federal agency responsible for enforcing drug control laws before its functions were absorbed into the Drug Enforcement Administration (DEA).
-
C.
Office of National Drug Control Policy
The Office of National Drug Control Policy is a U.S. federal agency that coordinates and oversees national drug-control strategy and policies across the government.
-
D.
DEA Special Operations Division
The DEA Special Operations Division is a specialized unit within the U.S. Drug Enforcement Administration that coordinates high-level, often international, counter-narcotics investigations and intelligence operations.
-
E.
DEA Intelligence Division
The DEA Intelligence Division is the branch of the U.S. Drug Enforcement Administration responsible for collecting, analyzing, and disseminating drug-related intelligence to support law enforcement operations and policy decisions.
- F. None of above. chosen
Statements (47)
| Predicate | Object |
|---|---|
| instanceOf |
federal law enforcement division
ⓘ
regulatory office ⓘ |
| aimsTo |
ensure controlled substances are available for legitimate medical use
ⓘ
prevent diversion of legal drugs into illicit markets ⓘ reduce prescription drug abuse ⓘ |
| country |
United States of America
ⓘ
surface form:
United States
|
| focusesOn |
legal controlled substances
ⓘ
pharmaceutical controlled substances ⓘ precursor chemicals ⓘ |
| hasAlternativeName |
DEA Office of Diversion Control
ⓘ
surface form:
DEA Diversion Control
DEA Office of Diversion Control ⓘ
surface form:
Office of Diversion Control
|
| headquartersLocation | Arlington, Virginia ⓘ |
| jurisdiction |
United States government
ⓘ
surface form:
United States federal government
|
| legalBasis |
Controlled Substances Act
ⓘ
federal controlled substances regulations ⓘ |
| locatedIn |
United States of America
ⓘ
surface form:
United States
Virginia ⓘ |
| mandate |
prevent, detect, and investigate diversion of controlled pharmaceuticals
ⓘ
regulate legitimate controlled substances industry ⓘ |
| operatedBy |
United States Department of Justice
ⓘ
surface form:
U.S. Department of Justice
|
| oversees |
DEA registration system for controlled substances handlers
ⓘ
recordkeeping requirements for controlled substances ⓘ reporting requirements for controlled substances ⓘ |
| parentAgency | Drug Enforcement Administration ⓘ |
| partOf | Drug Enforcement Administration ⓘ |
| responsibleFor |
administrative actions against registrants
ⓘ
civil actions related to diversion ⓘ enforcement of the Controlled Substances Act in diversion matters ⓘ investigating diversion of controlled substances ⓘ monitoring compliance with controlled substances regulations ⓘ oversight of legal controlled substances supply chain ⓘ preventing diversion of controlled substances ⓘ registration of controlled substances handlers ⓘ registration of distributors of controlled substances ⓘ registration of manufacturers of controlled substances ⓘ registration of pharmacies handling controlled substances ⓘ registration of practitioners prescribing controlled substances ⓘ regulating controlled substances distribution ⓘ supporting criminal investigations of diversion ⓘ |
| subjectOf | U.S. federal regulations on controlled substances diversion control ⓘ |
| subordinateTo | DEA Deputy Administrator ⓘ |
| usesProgram |
DEA Office of Diversion Control
self-linksurface differs
ⓘ
surface form:
DEA Diversion Control Program
|
| worksWith |
healthcare providers
ⓘ
law enforcement agencies ⓘ pharmaceutical manufacturers ⓘ pharmacies ⓘ state regulatory agencies ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: DEA Office of Diversion Control Description of subject: The DEA Office of Diversion Control is the division of the U.S. Drug Enforcement Administration responsible for preventing, investigating, and regulating the diversion of legal controlled substances into illegal channels.
Referenced by (4)
Full triples — surface form annotated when it differs from this entity's canonical label.
this entity surface form:
Office of Diversion Control
this entity surface form:
DEA Diversion Control
DEA Office of Diversion Control
→
usesProgram
→
DEA Office of Diversion Control
self-linksurface differs
ⓘ
this entity surface form:
DEA Diversion Control Program